Keyphrases
All-solid
28%
Associated Risk
14%
Breast Cancer
57%
Cancer Oncology
14%
Cancer Registry
14%
Cancer Risk
14%
Cancer Treatment Protocols
14%
Chemotherapy
100%
Childhood Cancer
100%
Childhood Cancer Survivors
100%
Childhood Cancer Treatment
14%
CNS Sarcoma
14%
Cox Proportional Hazards Regression Analysis
14%
Cumulative Incidence
14%
Cyclophosphamide
28%
Dose Effect
28%
Dose-response
14%
Doxorubicin
42%
Dutch
28%
Ewing Sarcoma
14%
Excess Absolute Risk
28%
First Diagnosis
28%
Leukemia
14%
Li-Fraumeni Syndrome
14%
Long-run Risk
100%
Medical Chart Review
14%
Multivariable
14%
Netherlands
28%
Risk Incidence
14%
Sarcoma
42%
Solid Cancer
57%
Standardized Incidence Ratio
28%
Subsequent Malignant Neoplasms
100%
Surveillance Guidelines
14%
Survivors
28%
Medicine and Dentistry
Breast Cancer
33%
Cancer Registry
8%
Cancer Risk
8%
Cancer Therapy
8%
Central Nervous System Leukemia
8%
Chemotherapy
100%
Childhood Cancer
100%
Cohort Analysis
100%
Connective Tissue Cancer
25%
Cumulative Incidence
8%
Cyclophosphamide
16%
Dose Response
8%
Doxorubicin
25%
Ewing Sarcoma
8%
Gene Linkage
8%
Li-Fraumeni Syndrome
8%
Malignant Neoplasm
100%
Oncology
8%
Proportional Hazards Model
8%
Standardized Incidence Ratio
16%
Immunology and Microbiology
Cyclophosphamide
100%
Dose Response
50%
Standardized Incidence Ratio
100%
Pharmacology, Toxicology and Pharmaceutical Science
Connective Tissue Cancer
25%